People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in …
Shield Therapeutics PLC on Wednesday reported significantly widened loss for 2017, as it progresses on Feraccru product study and commercialisation. The specialty pharmaceutical firm reported …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
